Explore our regular blog posts for fresh insights and trends in dermal fillers and toxins
Eastern Time on July 23, 2026
Save Dihexa is an angiotensin-IV-derived oligopeptide marketed as a research nootropic, and its honest safety picture starts with an absence: there are no published human clinical trials of Dihexa, and therefore no human safety, toxicology, or pharmacokinetic data of any kind
TB-500 distributes broadly through connective tissue, muscles, and joints throughout the body, which makes it particularly useful for patients dealing with multiple injury sites, diffuse connective tissue inflammation, or slower-healing chronic conditions that a localized peptide cannot fully address
The small molecule ligand was processed using AutoDockTools 1.5.7 software, including adding hydrogen bonds and assigning proper torsion angles to chemical bonds, and then exported in PDBQT format